phekolo ea morao-rao ea kankere ea matšoafo

Kankere ea morao-rao ea matšoafo, leha e le phephetso, e hlahisa tse ngata phekolo ea morao-rao ea kankere ea matšoafo likhetho tse reretsoeng ho lelefatsa bophelo le ho ntlafatsa boleng ba bophelo. Liphekolo tsena li tloha ho liphekolo tsa setso joalo ka chemotherapy le radiation ho isa mekhoeng e shebiloeng haholo joalo ka immunotherapy le kalafo e lebisitsoeng, hangata e sebelisoang hammoho ho loants'a lefu lena ka katleho. Ho khetha tse ntle ka ho fetisisa phekolo ea morao-rao ea kankere ea matšoafo moralo o hloka tlhahlobo e batsi ea litšobotsi tse khethehileng tsa mofetše le bophelo bo botle ba mokuli ka kakaretso.Kutloisiso ea Morao Morao Mofets'e Kankere ea Matšoafo Mofets'e oa mofetše ke mokhoa o sebelisoang ho hlalosa boholo ba mofetše 'meleng. Kankere ea morao-rao ea matšoafo hangata e bua ka Mothati oa III le Mothati oa IV. Ho utloisisa sethala sa hau se ikhethileng ho bohlokoa bakeng sa ho khetha se nepahetseng ka ho fetisisa phekolo ea morao-rao ea kankere ea matšoafo leano.Mohato oa III Kankere ea MatšoafoMothati oa III Kankere ea matšoafo e bolela hore mofetše o nametse ho li-lymph nodes tse haufi, empa eseng lithong tse hole. Ho itšetlehile ka boholo ba ho ata ka har'a sefuba, ho ka khoneha ho tlosa kankere ka ho buuoa, le hoja hangata sena se kopantsoe le tse ling. phekolo ea morao-rao ea kankere ea matšoafo Mekhoa.Mohato oa IV Kankere ea MatšoafoMothati oa IV Kankere ea matšoafo e bontša hore mofetše o na le metastasized, ho bolelang hore o nametse lithong tse hōle tse kang boko, masapo, sebete kapa litšoelesa tsa adrenal. Le hoja pheko e se monyetla o fokolang mothating ona, phekolo ea morao-rao ea kankere ea matšoafo e shebane le ho laola khōlo ea mofetše, ho kokobetsa matšoao le ho ntlafatsa boleng ba bophelo. E tsoetseng pele phekolo ea morao-rao ea kankere ea matšoafo likhetho li fumaneha ho laola ho ata le ho ntlafatsa boemo ba mokuli. Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa (https://baofahospital.com) e ikemiselitse ho ntšetsa pele lipatlisiso tsa mofetše le likhetho tsa kalafo. Tloaelo Kalafo Kalafo ea Mokhahlelo oa Morao-rao Kalafo ea Kankere ea Matšoafo OptionsChemotherapyChemotherapy e sebelisa lithethefatsi ho bolaea lisele tsa mofetše' meleng oohle. Hangata e sebelisoa e le mohato oa pele phekolo ea morao-rao ea kankere ea matšoafo bakeng sa kankere ea matšoafo ea morao-rao. Lithethefatsi tse tloaelehileng tsa chemotherapy bakeng sa mofetše oa matšoafo li kenyelletsa lithethefatsi tse thehiloeng ho platinum (cisplatin kapa carboplatin) tse kopantsoeng le lisebelisoa tse ling tse kang pemetrexed, gemcitabine, kapa docetaxel.Litlamorao: Litla-morao tse tloaelehileng li kenyelletsa ho nyekeloa ke pelo, ho hlatsa, mokhathala, ho lahleheloa ke moriri, le kotsi e eketsehileng ea tšoaetso. Hangata litla-morao tsena li ka laoloa ka meriana e tšehetsang.Kalafo ea Radiation TherapyRadiation e sebelisa maballo a matla a matla ho lebisa le ho bolaea lisele tsa mofetše sebakeng se itseng. E ka sebelisoa ho fokotsa lihlahala, ho kokobetsa bohloko, kapa ho laola ho nama ha mofetše bokong kapa masapong.Litlamorao: Litla-morao li itšetlehile ka sebaka se phekoloang 'me se ka kenyelletsa mokhathala, ho ruruha ha letlalo, le bothata ba ho metsa. Stereotactic body radiation therapy (SBRT) ke mofuta o nepahetseng haholoanyane oa radiation o fanang ka litekanyetso tse phahameng ka linako tse fokolang, ho fokotsa tšenyo ho lisele tse haufi. Targeted Therapy bakeng sa Kalafo Kalafo ea Mokhahlelo oa Morao-rao Kalafo ea Kankere ea MatšoafoLithethefatsi tse reriloeng li shebana ka ho khetheha le ho se tloaelehe ha lisele tsa mofetše tse li lumellang ho hola le ho ata. Hangata mekhoa ena ea phekolo e sebetsa ka litla-morao tse fokolang ho feta chemotherapy ea setso, empa e hloka tlhahlobo e khethehileng ea liphatsa tsa lefutso ho fumana hore na lisele tsa kankere li na le lipheo tse nepahetseng.EGFR InhibitorsEpidermal growth factor receptor (EGFR) inhibitors, tse kang gefitinib, erlotinib, afatinib, le osimertinib, tse lebisang liphetoho tsa EGFR tse atisang ho fumanoa liseleng tse seng tsa mofetše SCNLC. Hangata tsena ke tsa pele phekolo ea morao-rao ea kankere ea matšoafo dikgetho bakeng sa bakuli ba liphetoho tsena.Litlamorao: Litla-morao tse tloaelehileng li kenyelletsa lekhopho, letšollo le letlalo le omeletseng.ALK InhibitorsAnaplastic lymphoma kinase (ALK) inhibitors, tse kang crizotinib, ceritinib, alectinib, brigatinib, le lorlatinib, sepheo sa ho hlophisa bocha liphatsa tsa lefutso tsa ALK, phetoho e 'ngoe e tloaelehileng ea mokhanni ho NSCLC.Litlamorao: Litla-morao li fapana ho latela sethethefatsi se itseng empa li ka kenyelletsa liphetoho tsa pono, ho nyekeloa ke pelo, mokhathala le mathata a sebete. Sehlopha se inehetseng sa Shandong Baofa Cancer Research Institute se ikemiseditse ho ntlafatsa diphetho tsa mokudi.Mefuta e meng e Lebisitsoeng ho PhekoloLiphekolo tse ling tse lebisitsoeng holima liphetoho tse itseng, tse kang ROS1, BRAF, MET, le RET. Ho etsa liteko tsa liphetoho tsena tsa liphatsa tsa lefutso ho bohlokoa ho khetholla bakuli ba ka ruang molemo liphekolong tsena.Immunotherapy bakeng sa Kalafo Kalafo ea Mokhahlelo oa Morao-rao Kalafo ea Kankere ea MatšoafoImmunotherapy e sebelisa matla a sesole sa 'mele sa mokuli ho loantša mofetše. Lithethefatsi tsena li thusa sesole sa 'mele ho lemoha le ho hlasela lisele tsa mofetše. Immunotherapy e fetotse bophelo bo botle phekolo ea morao-rao ea kankere ea matšoafo ea lik'hemik'hale tse ngata, ho akarelletsa le kankere ea matšoafo.PD-1/PD-L1 InhibitorsPD-1 le PD-L1 inhibitors, tse kang pembrolizumab, nivolumab, atezolizumab, le durvalumab, li thibela ho sebelisana pakeng tsa PD-1 (protheine e liseleng tsa 'mele) le PD-L1 (protheine e liseleng tsa kankere). Thibelo ena e lokolla 'mariki' sesoleng sa 'mele, e e lumellang ho hlasela lisele tsa mofetše ka katleho. Pembrolizumab hangata e sebelisoa joalo ka mola oa pele phekolo ea morao-rao ea kankere ea matšoafo khetho ho bakuli ba nang le polelo e phahameng ea PD-L1.Litlamorao: Litla-morao li ka kenyelletsa mokhathala, lekhopho, letšollo, lefu la matšoafo (ho ruruha ha matšoafo), le mathata a qoqotho. Litla-morao tsena hangata li laoleha ka li-corticosteroids kapa li-immunosuppressants tse ling.CTLA-4 InhibitorsCTLA-4 inhibitors, joalo ka ipilimumab, e sebetsa ka mokhoa o fapaneng oa ho kenya tšebetsong sesole sa 'mele. Ka linako tse ling li sebelisoa hammoho le PD-1 inhibitors.Litlamorao: Litla-morao li tšoana le tsa PD-1 inhibitors empa li ka ba matla le ho feta. phekolo ea morao-rao ea kankere ea matšoafo likhetho tse so fumaneheng ka bongata. Ho nka karolo litekong tsa bongaka ho ka fana ka melemo e ka bang teng le ho kenya letsoho ntlafatsong ea lipatlisiso tsa mofetše. Setsebi sa hau sa oncologist se ka u thusa ho tseba hore na teko ea kliniki ke khetho e nepahetseng bakeng sa hau. Tlhokomelo ea Palliative CarePalliative e shebane le ho imolla matšoao le ho ntlafatsa boleng ba bophelo ho bakuli ba nang le mafu a tebileng, joalo ka mofets'e oa morao oa matšoafo. E ka fanoa hammoho le tse ling phekolo ea morao-rao ea kankere ea matšoafo ’me e akarelletsa ho laola bohloko, ho hema ka thata, mokhathala le matšoao a mang. Tlhokomelo ea boiketlo e boetse e sebetsana le litlhoko tsa maikutlo le tsa moea tsa bakuli le malapa a bona. phekolo ea morao-rao ea kankere ea matšoafo e hloka mokhoa o fapaneng o kenyelletsang sehlopha sa litsebi, ho kenyeletsoa lingaka tsa oncologists, li-radiation oncologists, pulmonologists, lingaka tse buoang, litsebi tsa radiology, le litsebi tsa tlhokomelo ea bophelo bo botle. Sehlopha sena se sebetsa 'moho ho theha semelo sa motho ka mong phekolo ea morao-rao ea kankere ea matšoafo moralo o thehiloeng litlhoko le lipakane tsa mokuli ka bomong. Mehopolo ea Mokhoa oa Bophelo Ho boloka mokhoa oa bophelo o phetseng hantle ho ka bapala karolo ea bohlokoa ho laola mofetše oa matšoafo oa morao-rao. Sena se kenyeletsa:Phepo: Ho ja lijo tse leka-lekaneng ho ka thusa ho boloka matla le maemo a matla.Boikoetliso: Boikoetliso bo itekanetseng bo ka ntlafatsa maikutlo, ho fokotsa mokhathala le ho ntlafatsa bophelo bo botle ka kakaretso.Ho Khaotsa ho Tsuba: Ho tlohela ho tsuba ke habohlokoa, esita le nakong ea morao-rao, ho ntlafatsa tšebetso ea matšoafo le karabelo ho phekolo ea morao-rao ea kankere ea matšoafo.Tšehetso ea Maikutlo: Ho batla tšehetso ea maikutlo ho tsoa ho ba lelapa, metsoalle, lihlopha tsa tšehetso, kapa lingaka ho ka thusa ho sebetsana ka katleho le mathata a maikutlo a mofetše oa matšoafo. phekolo ea morao-rao ea kankere ea matšoafo likhetho li fumaneha ho lelefatsa bophelo le ho ntlafatsa boleng ba bophelo. A motho ka mong phekolo ea morao-rao ea kankere ea matšoafo moralo, o entsoeng ka therisano le sehlopha sa litsebi tse fapaneng, o bohlokoa bakeng sa ho ntlafatsa sephetho. Lipatlisiso tse tsoelang pele le mekhoa e mecha li lebisa mekhoeng e mecha le e sebetsang haholoanyane bakeng sa phekolo ea morao-rao ea kankere ea matšoafo letsatsi le letsatsi. Litsebi tse inehetseng tsa Shandong Baofa Cancer Research Institute li ka pele-pele ntoeng ena. Papiso ea Tloaelehileng Kalafo Kalafo ea Mokhahlelo oa Morao-rao Kalafo ea Kankere ea Matšoafo Dikgetho Kalafo Kalafo ea Mokhahlelo oa Morao-rao Kalafo ea Kankere ea Matšoafo Mechanism Common Side Effects Khemotherapy e bolaea lisele tse arohaneng ka potlako Ho nyekeloa ke pelo, Mokhathala, Moriri o Loss Radiation Therapy Tšenyo DNA ea lisele tsa mofetše Mokhathala, Skin Irritation EGFR Inhibitors Blocks EGFR signing Rash, Lets'ollo PD-1/PD-L1 Inhibitors Releases Immune system merero ea thuto feela 'me ha ea lokela ho nkoa e le keletso ea bongaka. Kamehla buisana le mofani oa tlhokomelo ea bophelo bakeng sa tlhahlobo le phekolo ea morao-rao ea kankere ea matšoafo dikgetho.